In vivo regulation of von Willebrand factor synthesis -: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs

被引:27
作者
Brouland, JP [1 ]
Egan, T
Roussi, J
Bonneau, M
Pignaud, G
Bal, C
Vaiman, M
André, P
Hervé, P
Mazmanian, GM
Drouet, L
机构
[1] Hop Lariboisiere, Serv Anat & Cytol Pathol, F-75475 Paris 10, France
[2] Hop Lariboisiere, Inst Vaisseaux & Sang, F-75475 Paris, France
[3] Univ N Carolina, Chapel Hill, NC 27515 USA
[4] Hop St Louis, INSERM, U353, Paris, France
[5] Hop Raymond Poincare, Hematol Lab, Garches, France
[6] INRA, LEPSD, Jouy En Josas, France
[7] CEA, INRA, Jouy En Josas, France
[8] Hop Marie Lannelongue, Physiol Lab, F-92350 Le Plessis Robinson, France
[9] Hop Marie Lannelongue, Ctr Medicochirurg, F-92350 Le Plessis Robinson, France
关键词
endothelial cells; lung transplantation; von Willebrand factor; immunohistochemistry; pigs;
D O I
10.1161/01.ATV.19.12.3055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the regulation of plasma von Willebrand factor (vWF) and its in situ production by endothelial cells (ECs), 12 swine leukocyte antigen (SLA)-compatible left lung transplantations were performed. Normal lungs were transplanted into 10 pigs homozygous for von Willebrand disease and into 2 normal pigs, Additionally, 1 normal pig underwent pneumonectomy, and 1 SLA-incompatible lung transplantation between normal pigs was performed. None of the transplanted animals received immunosuppressive therapy. Plasma vWF level was evaluated by ELISA and multimeric pattern. EC vWF content was assessed by immunohistochemistry. Global hemostasis was assessed by standardized ear bleeding time. Six of 12 SLA-compatible lung transplantations and the incompatible transplantation were successful and were used for the study. The functions and the viability of ECs, reflected by their ability to produce VWF and normal multimeric plasma VWF pattern, were preserved in SLA-compatible and -incompatible lung transplantations. vWF production was preserved in ECs that initially synthesized it. EC constitutive and storage pathways are modulated differently according to transplantation compatibility and severity of rejection. In SLA-compatible lung transplantations without histological evidence of rejection, the production of VWF was preserved, whereas constitutive vWF secretion appeared to be altered in cases with minor histological signs of rejection. In pigs with von Willebrand disease that were transplanted with normal lungs without sign of rejection, plasma VWF was significantly increased in an amount expected from the estimated production of a normal lung. In the transplanted normal lung, there was no vWF overexpression by the ECs and no recruitment of ECs that initially did not express VWF. In SLA-incompatible transplantation, ECs were morphologically normal with increased and blurred vWF labeling, whereas plasma VWF levels remained normal, reflecting that EC activation is associated with an increased vWF production with probable diversion to storage pathway. This model depicts the changes of EC regulation of vWF secretion in pig lung transplants. However, this model cannot be directly extrapolated to human organ transplantation because animals did not receive any immunosuppressive therapy, which may be toxic to ECs.
引用
收藏
页码:3055 / 3062
页数:8
相关论文
共 63 条
[41]   ABSENCE OF INCORPORATION OF PLASMA VON-WILLEBRAND-FACTOR INTO PORCINE PLATELET ALPHA-GRANULES [J].
ROUSSI, J ;
DROUET, L ;
SIGMAN, J ;
VAIMAN, M ;
PIGNAUD, G ;
BONNEAU, M ;
MASSE, JM ;
CRAMER, EM .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (03) :661-668
[42]  
Roussi J, 1996, EXP HEMATOL, V24, P585
[43]   Platelet functions and haemostasis parameters in pigs: Absence of side effects of a procedure of general anaesthesia [J].
Roussi, J ;
Andre, P ;
Samama, M ;
Pignaud, G ;
Bonneau, M ;
Laporte, A ;
Drouet, L .
THROMBOSIS RESEARCH, 1996, 81 (03) :297-305
[44]  
SADLER JE, 1995, THROMB HAEMOSTASIS, V74, P161
[45]  
SAKARIASSEN KS, 1986, BLOOD, V67, P1515
[46]   Endothelial activation and cytokine expression in human acute cardiac allograft rejection [J].
Salom, RN ;
Maguire, JA ;
Hancock, WW .
PATHOLOGY, 1998, 30 (01) :24-29
[48]   THE BINDING OF PURIFIED FACTOR-VIII VONWILLEBRAND-FACTOR TO COLLAGENS OF DIFFERING TYPE AND FORM [J].
SCOTT, DM ;
GRIFFIN, B ;
PEPPER, DS ;
BARNES, MJ .
THROMBOSIS RESEARCH, 1981, 24 (5-6) :467-472
[49]   INDUCIBLE SECRETION OF LARGE, BIOLOGICALLY POTENT VONWILLEBRAND-FACTOR MULTIMERS [J].
SPORN, LA ;
MARDER, VJ ;
WAGNER, DD .
CELL, 1986, 46 (02) :185-190
[50]   Use of balloon-expandable metallic stents in the management of bronchial stenosis and bronchomalacia after lung transplantation [J].
Susanto, I ;
Peters, JI ;
Levine, SM ;
Sako, EY ;
Anzueto, A ;
Bryan, CL .
CHEST, 1998, 114 (05) :1330-1335